Free Trial

Thermo Fisher Scientific (TMO) Competitors

Thermo Fisher Scientific logo
$426.65 +7.95 (+1.90%)
Closing price 03:59 PM Eastern
Extended Trading
$424.10 -2.55 (-0.60%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WAT

Should you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector.

Thermo Fisher Scientific vs. Its Competitors

Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Thermo Fisher Scientific had 55 more articles in the media than Medpace. MarketBeat recorded 62 mentions for Thermo Fisher Scientific and 7 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.21 beat Medpace's score of 0.93 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Thermo Fisher Scientific
45 Very Positive mention(s)
6 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B4.39$404.39M$13.1024.62
Thermo Fisher Scientific$42.88B3.76$6.34B$17.0525.02

78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

Medpace presently has a consensus price target of $344.82, suggesting a potential upside of 6.92%. Thermo Fisher Scientific has a consensus price target of $603.05, suggesting a potential upside of 41.35%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.21
Thermo Fisher Scientific
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.80

Medpace has a net margin of 19.31% compared to Thermo Fisher Scientific's net margin of 15.19%. Medpace's return on equity of 54.36% beat Thermo Fisher Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace19.31% 54.36% 20.81%
Thermo Fisher Scientific 15.19%17.15%8.47%

Summary

Thermo Fisher Scientific beats Medpace on 10 of the 16 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMO vs. The Competition

MetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$158.06B$6.70B$5.46B$20.45B
Dividend Yield0.41%1.21%5.24%3.72%
P/E Ratio25.0224.9227.0127.80
Price / Sales3.7684.07380.1449.81
Price / Cash13.9421.4826.2118.22
Price / Book3.294.787.994.58
Net Income$6.34B$173.18M$3.16B$982.91M
7 Day Performance1.26%2.66%3.69%1.31%
1 Month Performance6.13%-0.49%2.91%4.85%
1 Year Performance-20.40%18.78%34.30%14.09%

Thermo Fisher Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMO
Thermo Fisher Scientific
4.9923 of 5 stars
$426.65
+1.9%
$603.05
+41.3%
-22.5%$158.06B$42.88B25.02125,000Positive News
Analyst Forecast
MEDP
Medpace
4.4512 of 5 stars
$312.45
+0.6%
$344.82
+10.4%
-20.8%$8.98B$2.16B23.855,900
A
Agilent Technologies
4.7243 of 5 stars
$117.92
-1.0%
$140.92
+19.5%
-5.7%$33.50B$6.51B29.1218,100Positive News
Analyst Forecast
AMN
AMN Healthcare Services
4.3218 of 5 stars
$20.97
+0.4%
$32.08
+53.0%
-56.2%$802.73M$2.98B-4.842,968News Coverage
DHR
Danaher
4.8864 of 5 stars
$197.07
-0.9%
$248.61
+26.2%
-16.6%$141.04B$23.82B38.2763,000Positive News
Analyst Forecast
HAE
Haemonetics
4.8803 of 5 stars
$74.92
+1.5%
$96.80
+29.2%
-11.7%$3.60B$1.36B22.633,023Positive News
MCK
McKesson
4.6272 of 5 stars
$728.52
+0.4%
$696.42
-4.4%
+25.1%$91.15B$359.05B28.2075,000Positive News
Analyst Upgrade
QGEN
Qiagen
3.8869 of 5 stars
$47.95
+0.4%
$49.40
+3.0%
+18.8%$10.66B$1.98B120.225,765Dividend Announcement
WST
West Pharmaceutical Services
4.7576 of 5 stars
$217.78
-0.5%
$320.00
+46.9%
-31.3%$15.65B$2.89B34.1910,600
MTD
Mettler-Toledo International
4.3297 of 5 stars
$1,170.88
-1.2%
$1,300.36
+11.1%
-11.7%$24.33B$3.87B29.2018,000Positive News
Analyst Forecast
WAT
Waters
4.5305 of 5 stars
$348.87
-1.0%
$388.00
+11.2%
+21.0%$20.76B$2.96B31.668,200Trending News
Analyst Upgrade

Related Companies and Tools


This page (NYSE:TMO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners